Crossmark

Edaravone attenuates doxorubicin-induced oral mucosal injury via modulation of oxidative stress, inflammatory signaling, and the SIRT1/TLR4/NF-kB/ACE2 axis in rats

Crossref DOI link: https://doi.org/10.1186/s12903-025-07148-y

Published Online: 2025-11-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zeytinoglu, Mert https://orcid.org/0000-0002-1178-9743
Erdil, Aras

Çolak, Sefa

Demirsoy, Mustafa Sami

Akin, Ali Tuğrul

Değer, Necla

Karabulut, Derya

Gül, Serdar Savaş

Aygun, Hatice

Erbaş, Oytun
License Information

Text and Data Mining valid from 2025-11-26

Version of Record valid from 2025-11-26
More Information

Article History

Received: 11 July 2025

Accepted: 10 October 2025

First Online: 26 November 2025

Declarations

:

: The protocol was approved by the local ethics committee Tokat Gaziosmanpaşa University (2020 HADYEK-15; Approval number: 51879863-105).The animals used in this study were obtained from the Experimental Animal Research Center of Tokat Gaziosmanpaşa University.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below